No Detail Found!

Hypercholesterolemia as a causative risk factor for non-alcoholic fatty liver disease

Author(s)
Sarwat Abbasi Department of Biochemistry, Ayub Medical College, Abbottabad, Pakistan.
Saadia Sadiq Department of Biochemistry, Abbottabad International Medical College,Abbottabad-,Pakistan
Nadia Haleem Department of FBiochemistry, Department of Biochemistry, Ayub Medical College, Abbottabad, Pakistan.
Salma Shazia Department of Forensic Medicine, Department of Biochemistry, Ayub Medical College, Abbottabad, Pakistan.
Sara Jadoon Department of Anatomy, Ayub Medical College,Abbottabad-,Pakistan
Muhammad Israr Department of Biochemistry, Bacha Khan Medical College,Mardan-,Pakistan
Abstract
Background: Increased serum Cholesterol level is a known risk factor for cardiovascular diseases. Derangements in serum Cholesterol levels will affect normal hepatic Cholesterol homeostasis resulting in hypercholesterolemia. Non-Alcoholic fatty liver disease (NAFLD) initially asymptomatic but can lead to cirrhosis and hepatocellular carcinoma from mild steatosis to nonalcoholic steatohepatitis. The objective of this study is to find out hypercholesterolemia as a causative risk factor in NAFLD patients. This will help to prevent the development and progression of the disease. Methods: This cross-sectional study was conducted from 16th August 2021 to 16th August 2022 at Ayub Medical institute Abbottabad. Random sampling technique was used. Sample size was 100, in which 50 were diagnosed cases of liver disease and 50 normal subjects diagnosed on ultrasound. A questionnaire was designed. Subjects between 40-65 years age group were selected after informed consent and confidentiality. Data was collected from the out-patient department of medical and surgical unit and analysed with the help of SPSS-22.00. Chi-square test was used. Enzymatic kit method was used for serum cholesterol and triglycerides estimation. BMI was derived from the mass (weight) and height of the person. Results: It was found that 48% study subjects with NAFLD shows high serum Cholesterol levels while 52% subjects with NAFLD were found within normal limits but 10% individuals with no fatty infiltration had high serum Cholesterol levels while 90% without NAFLD had shown normal serum Cholesterol levels. Significant p-value of <0.001 was found between presence of NAFLD and high serum Cholesterol levels. Significant association was also found among serum Cholesterol and serum Triglyceride levels showing strong association of serum cholesterol levels with NAFLD and raised serum triglycerides levels with p-value 0.001. Similarly, significant association was found between serum cholesterol levels and BMI with p-value ?0.001. Conclusion: Highly significant association was found between Hypercholesterolemia and non-alcoholic fatty liver disease. It suggests hypercholesterolemia as a causative risk factor for NAFLD.
Publication Details
Page(s) 573-577
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
hypercholesterolemia, Non-alcoholic fatty liver disease (NAFLD)., Hepatic Disorder
References
Huh Y,Cho YJ,Nam GE .2022 .Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. J Obes Metab Syndr, 31(1) : 17-27.
Targher G,Tilg H,Byrne CD .2021 .Non-alcoholic fatty Liver Disease: a multisystem Disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol, 6(7) : 578-88.
.2023 .Lifestyle interventions in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 20(11) : 708-22.
Simon TG,Roelstraete B,Hagström H,Sundström JL,udvigsson JF .2022 .Non-alcoholic fatty Liver Disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut, 71(9) : 1867-75.
Pirillo A,Norata GD .2023 .The burden of hypercholesterolemia and ischemic heart disease in an ageing world. Pharmacol Res, 193 : 106814.
Nguyen P,Leray V,Diez M,Serisier S,Le Bloc'h J,Siliart B .2008 .Liver lipid metabolism. J Anim Physiol Anim Nutr, 92(3) : 272-83.
Ipsen DH,Lykkesfeldt J,Tveden-Nyborg P .2018 .Molecular mechanisms of hepatic lipid accumulation in nonalcoholic fatty liver disease. Cell Mol Life Sci, 75(18) : 3313-27.
. .. Nonalcoholic Fatty Liver Disease and 1., : .
Agonists. Thyroid .2019 .Roles of Thyroid Hormones, Metabolites, and. , 29(9) : 1173-91.
Wadström BN,Wulff AB,Pedersen KM,Jensen GB,Nordestgaard BG .2022 .Elevated remnant cholesterol increases the risk of peripheral artery Disease, Myocardial Infarction, and ischaemic Stroke: a cohort - based study. Eur Heart J, 43(34) : 3258-69.
Huh JH,Roh E,Lee SJ,Ihm SH,Han KD,Kang JG .2022 .Remnant cholesterol is an Independent predictor of type 2 Diabetes: a Nationwide Population-based Cohort Study. Diabetes Care, 46 : 305-12.
Huang H,Guo Y,Liu Z,Zeng Y,Chen Y,Xu C .2022 .Remnant cholesterol predicts long-term mortality of patients with metabolic dysfunction-associated fatty Liver Disease. J Clin Endocrinol Metab, 107 : 3295-303.
Zou Y,Kuang M,Zhong Y,Jiang C .2023 .Remnant cholesterol can identify individuals at higher risk of metabolic syndrome in the general population. Sci Rep, 13(1) : 5957.
Huang H,Xie J,Zeng Y,Liu Z,Miao M,Xu L .2023 .Remnant cholesterol independently predicts the development of nonalcoholic fatty Liver Disease. J Clin Endocrinol Metab, 108(11) : 2907-15.
Miao Y Tao H. Association .2023 .between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty Liver Disease in non-obese populations: a Chinese longitudinal prospective cohort study. BMJ Open, 13(5) : eo69440.
Chin J,Mori TA,Adams LA,Beilin LJ,Huang RC,Olynyk JK .2020 .Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty Liver Disease in adolescents. JHEP Rep, 2(6) : 100150.
Makri E,Goulas A,Polyzos SA .2021 .Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res, 52(1) : 25-37.
Mantovani A,Csermely A,Petracca G,Beatrice G,Corey KE,Simon TG .2021 .Non-alcoholic fatty Liver Disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 6(11) : 903-13.
Stürzebecher PE,Katzmann JL,Laufs U .2023 .. Eur Heart J, 44(16) : 1446-8.
Huang H,Wang J,Wu L,Ruan J,Hou L,Shen C .2023 .Remnant cholesterol and severity of nonalcoholic fatty liver disease. Diabetol Metab Syndr, 15(1) : 238.
Dutta S,Singhal AK,Suryan V,Chandra NC .2024 .Obesity: An Impact with Cardiovascular and Cerebrovascular Diseases. Ind J Clin Biochem, 39(2) : 168-78.
Koo HC,Tan LK,Lim GP,Kee CC,Omar MA .2023 .Obesity and Its Association with Undiagnosed Diabetes Mellitus, High Blood Pressure and Hypercholesterolemia in the Malaysian Adult Population: A National Cross -Sectional Study Using NHMS Data. Int J Environ Res Public Health, 20(4) : 3058.
Fang M,Wang D,Coresh J,Selvin E.,Undiagnosed E. .2022 .Diabetes mellitus in U.S. Adults: Prevalence and Trends. Diabetes Care, 45(9) : 1994-2002.
Herman WH,Ye W,Griffin SJ,Simmons RK,Davies MJ,Khunti K .2015 .Early Detection and Treatment of Type 2 Diabetes mellitus Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo - Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes mellitus in Primary Care (ADDITION-Europe). Diabetes Care, 38(8) : 1449-54.
Anderson EL,Howe LD,Jones HE,Higgins JP,Lawlor DA,Fraser A. .2015 .the prevalence of non- alcoholic fatty liver disease in children and adolescents: a systemic review and meta-analysis. PLoS One, 10(10) : e0140908.
Kaikkonen JE,Kresanov P,Ahotupa M,Jula A,Mikkila V,Viikari JS .2016 .Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the cardiovascular risk in young finns study. Free Radic Res, 50(4) : 396-404.
Wang J,Zhu W,Huang S,Xu L,Miao M,Wu C .2017 .Serum Apo B levels independently predict the development of non-alcoholic fatty liver disease: a 7-year prospective study. Liver Int, 37 : 1202-8.
Gaggini M,Morelli M,Buzzigoli E,De Fronzo RA,Bugianesi E,Gastaldelli A .2013 .Non- alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diease. Nutrients, 5 : 1544-60.
Lee SB,Park GM,Lee JY,Lee BU,Park JH,Kim BG .2018 .Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study. J Hepatol, 68(5) : 1018.
0

Citations

0

Downloads

53

Views